An artificial intelligence (AI) -based diagnostic system, LungDiag, to diagnose respiratory diseases.
Poseida lines up another allogeneic CAR-T partner, allying with Astellas on solid tumors
Astellas will buy about 8.8% of Poseida Therapeutics for $25 million, and match that with a one-time payment for right of first refusal to license